Back to Agenda
Session 2 - ICH Guideline E5, 17 Training
Session Chair(s)
Ryuta Nakamura, PHD
Review Director, Office of New Drug II, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Speaker(s)
Yoko Aoi, PHD
Coordination Director - Office of Review Management, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
E5/E17: Ethnic Factors in the Acceptability of Foreign Clinical Data; Planning and Design of Multi-reginal Clinical Trials -1 (Regulatory Agency’s viewpoint)
Osamu Komiyama
Senior Manager, Statistical Research & Data Science, Pfizer R&D Japan G.K., Japan
E5/E17: Ethnic Factors in the Acceptability of Foreign Clinical Data; Planning and Design of Multi-regional Clinical Trials -2 (Industry’s viewpoint)
Have an account?